All News
|
Research Feature
Cardiovascular disease remains the leading cause of death worldwide. This is why Nicole Redmond, M.D., Ph.D., M.P.H., chief of the Clinical Applications and Prevention branch in NHLBI’s Division of Cardiovascular Sciences, is bringing attention to silent pieces of information, like elevated blood pressure or cholesterol. When they go unchecked...
Showing 10 out of 283 results
|
News Release
The National Institutes of Health awarded nearly $470 million to build a national study population of diverse research volunteers and support large-scale studies on the long-term effects of COVID-19. The NIH Researching COVID to Enhance Recovery (RECOVER) Initiative made the parent award to New York University (NYU) Langone Health, New York City...
|
News Release
The final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) demonstrate that COVID-19 convalescent plasma did not prevent disease progression in a high-risk group of outpatients with COVID-19, when administered within the first week of their symptoms. The trial was stopped in February 2021 due to lack of efficacy...
|
Media Advisory
WHAT: A three-part Science of Sleep Series will launch Tuesday afternoons in August through Facebook Live. Researchers will discuss how children and adults can put the latest sleep science into practice to support optimal health outcomes throughout the lifespan. Other topics to be discussed include emerging research and public health opportunities...
|
News Release
A large clinical trial conducted worldwide shows that treating moderately ill hospitalized COVID-19 patients with a full-dose blood thinner reduced their need for organ support, such as mechanical ventilation, and improved their chances of leaving the hospital. However, the use of this treatment strategy for critically ill COVID-19 patients...
|
News Release
Findings underscore need for early treatment to prevent future cardiovascular disease Children with obstructive sleep apnea are nearly three times more likely to develop high blood pressure when they become teenagers than children who never experience sleep apnea, according to a new study funded by the National Heart, Lung, and Blood Institute...
|
News Release
A new study by researchers at the National Institutes of Health and their colleagues has found that SARS-CoV-2, the virus that causes COVID-19, does not appear to pose a threat to the safety of the nation’s blood supply. The analysis, published in Transfusion, supports current donor screening guidelines, including those used by the U.S. Food and...
|
Statement
On World Asthma Day, the National Institutes of Health reaffirms its commitment to research to improve the lives of people with asthma. More than 25 million people in the United States have asthma, including 5.1 million children, according to the Centers for Disease Control and Prevention. This chronic lung disease can reduce quality of life...
|
News Release
Los Institutos Nacionales de la Salud (NIH, por sus siglas en inglés) han autorizado $29 millones de dólares en subvenciones adicionales para la Coalición “Alianza de Participación Comunitaria (CEAL, por sus siglas en inglés) de NIH contra las disparidades del COVID-19”. Esta financiación , parte del Plan de Rescate Estadounidense, esta dirigida a...
|
News Release
To bolster research to help communities disproportionately affected by COVID-19, the National Institutes of Health is funding $29 million in additional grants for the NIH Community Engagement Alliance (CEAL) Against COVID-19 Disparities. This funding was supported by the American Rescue Plan. The awards will provide $15 million to 11 teams already...
|
News Release
A clinical trial shows that cell-based therapy can be safe and feasible for patients with chronic heart failure—patients who currently have limited treatment options. The researchers also reported lower rates of death and hospitalization as well as improvements in quality of life for some. Presented November 13, 2020 at the American Heart...